MedTrace Logo

Growth Hormone in Obese Cases With Covid-19

NCT04532554 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2020-09-16

No results posted yet for this study

Summary

The use of growth hormone in obese cases with COVID-19 may help them to recover earlier.

Conditions

  • Covid19

Interventions

DRUG

Growth Hormone

Recombinant growth hormone will be used

DRUG

Placebo

Saline injection with the same amount

Sponsors & Collaborators

  • ClinAmygate

    lead OTHER

Principal Investigators

  • Emad R Issak, MD · Assalam Clinics

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-26
Primary Completion
2020-12-10
Completion
2020-12-20

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04532554 on ClinicalTrials.gov